tures. [24][25][26][27] [28] Verfaillie et al 30, 31 showed that stromal-derived factors syner- for ex vivo stem cell expansion and manipulation. Further-
more, SCM was used in combination with multiple cytokine combinations at optimal concentrations, because these cytokines are already employed in clinical ex vivo stem cell Introduction expansion and manipulation protocols. [6] [7] [8] [9] [10] [11] [12] The assessment of different HSC subsets was facilitated by the recently Mobilized peripheral blood stem cells (PBSC) are increasingly developed human CAFC assay wherein the CAFC weeks 2 to used to restore the formation of blood cells after high-dose 4 are used as tentative indicators of progenitor cell activity chemotherapy for solid tumors and hematological cancers. [1] [2] [3] [4] [5] and transiently repopulating HSC, while frequencies of CAFC For this reason PBSC are important target cells for ex vivo weeks 6 to 8 are interpreted as indicators of more primitive, hematopoietic stem cell (HSC) manipulation, expansion and long-term repopulating stem cells. 27, 34 These tools allowed us gene therapy. [6] [7] [8] [9] [10] [11] [12] It has been shown that hematopoietic stroma to study the SCM effect and its synergy with different multiple supports proliferation and more recently it has been reported cytokine combinations on the maintenance and expansion of that it may also enhance retroviral infection of HSC. [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] In different human stem cell subsets. In addition, by using differaddition, several investigators have shown that primary stroent stromal cell lines we were able to compare their colonymal cells can be replaced by cell lines to support HSC culstimulating activity with their ability to support HSC maintenance and expansion.
Materials and methods

CD34
+ cells in 1 ml medium were cultured at 37°C and 5% CO 2 . After 7 days of culture, the cells were collected from the dishes after scraping with a cell scraper (Greiner) and rinsing Peripheral blood stem cells with IMDM. After washing, the cells were resuspended in IMDM and plated in CFC or CAFC assays. Semisolid cultures Fifteen leukapheresis products from eight patients with multiple myeloma, five with non-Hodgkin lymphoma, one with were performed in the same serum-free medium containing 1% methylcellulose (Methocel, Stade, Germany). Burkitt lymphoma and one with Hodgkin disease in remission were used in this study. Before leukapheresis the HSC were mobilized to the blood after several courses of chemotherapy using granulocyte colony-stimulating factor (Filgrastim, Cytokines and antibodies recombinant-methionyl human G-CSF; Roche, Mijdrecht, The Netherlands) as described before. 34 After cell collection, For the liquid and semisolid cultures the following purified recombinant human cytokines and monoclonal antibodies excess of erythrocytes was removed using buffy coat centrifugation. Fresh or frozen and thawed cells were subjected to were kindly provided and used in the concentrations listed below: granulocyte-macrophage-CSF (GM-CSF; 10 ng/ml), IL-CD34 selection to enrich for HSC. For CD34 selection the following methods were used according to the guidelines of 6 (2000 U/ml), IL-11 (50 U/ml), anti-human-G-CSF (␣-hu-G-CSF; 1 g/ml), ␣-hu-GM-CSF (1 g/ml), ␣-hu-IL-11 (1 g/ml), the suppliers: Ceprate SC column (CellPro, Bothell, WA, USA), Dynal CD34 progenitor cell selection system (Dynal, ␣-hu-leukemia inhibitory factor (␣-hu-LIF; 1 g/ml), ␣-murine-G-CSF (␣-mu-G-CSF; 1 g/ml), ␣-mu-IL-11 (1 g/ml) and ␣-Oslo, Norway) and MACS CD34 isolation kit (Miltenyi Biotec, Bergisch Gladbach, Germany). Before CD34 selection using mu-LIF (1 g/ml) from Genetics Institute (Cambridge, MA, USA), G-CSF (100 ng/ml) and SCF (100 ng/ml) from Amgen the Dynal system and the MACS kit a density gradient was performed (1.077 g/ml, Lymphoprep; Nycomed, Oslo, (Thousand Oaks, CA, USA), IL-1␤ (100 U/ml) from Immunex (Seatle, WA, USA) and IL-3 (30 ng/ml) from Gist Brocades Norway). After selection the percentage of CD34
+ cells was determined as described before.
34 Table 1 shows the fre-(Delft, The Netherlands). Purified recombinant human erythropoietin (EPO; 1 U/ml) was purchased from Boehringer quency of the different stem cell subsets in the CD34 + selected PBSC before liquid culture as determined using flow cyto-(Mannheim, Germany) and, recombinant human macrophage inflammatory protein-1␣ (MIP-1␣; 100 ng/ml), ␣-mu-GM-CSF metry, colony-forming cell (CFC) and CAFC assays.
(10 g/ml) and ␣-porcine-transforming growth factor-␤1 (␣-TGF-␤1; 1 g/ml) from R&D Systems (Abingdon, UK).
Serum-free culture The cells were cultured in IMDM ietic cells to the plastic surface. The serum-free Iscove's modified Dulbecco's medium (IMDM) with Glutamax-1 (Gibco, with Glutamax-1 supplemented with 10% fetal calf serum (Hyclone, Logan, UT, USA), penicillin (100 U/ml), streptoBreda, The Netherlands) contained 1% bovine serum albumin (A9418; Sigma, St Louis, MO, USA), penicillin (100 U/ml; mycin (100 g/ml) and ␤-mercapto-ethanol (10 −4 M). The FBMD-1 cells were maintained at 33°C and 10% CO 2 and the Gibco) streptomycin (100 g/ml; Gibco), ␤-mercapto-ethanol (10 −4 M; Merck, Darmstadt, Germany), bovine insulin L87/4 and L88/5 cells at 37°C and 10% CO 2 . When the layers were confluent, the medium was removed and rinsed twice (10 g/ml; Gibco), cholesterol (15 M; Sigma), linolic acid (15 M; Merck), iron-satured human transferrin (0.62 g/l;
with IMDM. Serum-free medium as described above supplemented with 2% horse serum (Gibco) was added to the Intergen, Purchase, NY, USA), cytidine (1 g/ml; Sigma), adenosine (1 g/ml; Sigma), uridine (1 g/ml; Sigma), guanosconfluent stromal layers and conditioned for 7 days. The SCM were harvested, the non-adherent cells were removed by cenine (1 g/ml; Sigma), thymidine (1 g/ml; Sigma), 2′-deoxycytidine (1 g/ml; Sigma), 2′-deoxyadenosine (1 g/ml; Sigma), trifugation and the media were stored at −20°C until use. Control medium was prepared by parallel incubations without the 2′-deoxyguanosine (1 g/ml; Sigma). Two thousand to 60 000 Table 1 Mean frequency of different progenitor and CAFC subsets Table 2 Effect of antibodies against G-CSF, GM-CSF, IL-11 and LIF in mobilized PBSC after CD34 selection and before liquid culture on stroma-conditioned media-mediated colony-forming cell (CFC) expansion in liquid cultures simulated with IL-3, SCF and IL- Comparison between no SCM and with SCM: *, P Ͻ 0.05.
stromal cell lines. To block the negative effect of TGF-␤1 produce TGF-␤1, we added TGF-␤1-neutralizing antibodies to the SCM and the control experiments as a standard culture produced by the stromal cell lines on the recovery of HSC, ␣-TGF-␤1 was added to the SCM and control medium as a condition. The addition of FBMD-1 SCM significantly increased CFC expansion in cultures containing at least SCF standard culture condition. 27, [35] [36] [37] In the cultures, 50% SCM or control medium was used.
and IL-6 and resulted in on average 2.5-fold increased expansion as compared to 7-day liquid cultures without FBMD-1 SCM (Figure 1 ). We investigated whether cytokines known for
Colony-forming cell assay their effects on HSC, ie G-CSF, GM-CSF, IL-1␤, IL-3, IL-11, MIP-1␣ or combinations of these could explain this SCM Quantification of the number of colony-forming units effect. Irrespective of the modulating effects of additional cytogranulocyte/macrophage (CFU-GM) and burst-forming units kines on CFC expansion in the presence of SCF and IL-6, erythroid (BFU-E) was performed using a semisolid CFC assay FBMD-1 SCM always increased the expansion. containing EPO, G-CSF, GM-CSF, IL-3 and SCF as described
To compare the effect of FBMD-1 SCM with SCM of two before. 34 CFU-GM and BFU-E were counted on day 14 of human stromal cell lines (ie L87/4 and L88/5), CFC expansion culture in the same dish.
was done in liquid cultures containing either no cytokines or various combinations of cytokines in the absence or presence of these SCM. Both SCM increased the CFC production in
Cobblestone area forming cell assay serum-low cultures with different multi-cytokine combinations tested (Figure 2 ). Even in cultures without any other Limiting dilution CAFC assays using stromal feeders from the cytokines L88/5 SCM resulted in a 91% CFC maintenance. In FBMD-1 murine stromal cell line were prepared and maincultures containing IL-3, SCF, IL-6, G-SCF, GM-CSF, IL-11 and tained as described before.
27, 34 Briefly, the cells were cultured additional L88/5 SCM there was a 13.8-fold CFC expansion at 33°C and 10% CO 2 in CAFC medium. IL-3 (10 ng/ml) and as compared to CFC content before culture. G-CSF (20 ng/ml) were added weekly to the cultures. CAFC
To investigate whether the effect of SCM could be explained assays were performed on confluent stromal layers of FBMDby known stromal cell-derived cytokines we added species-1 cells in flat-bottom 96-well plates. CD34
+ cells were overspecific antibodies against G-CSF, GM-CSF, IL-11 and LIF to laid in a limiting dilution setup with input values ranging cultures otherwise stimulated by SCM and IL-3/SCF/IL-6. between one and 2000 CD34
+ cells per well. Twelve dilutions Table 2 shows that these antibodies could not abrogate the two-fold apart were used for each sample with 15 replicate effect of SCM addition, indicating that the cytokines G-CSF, wells per dilution. The percentage of wells with at least one GM-CSF, IL-11 and LIF were not responsible for the SCMphase-dark hematopoietic clone of at least five cells (ie enhanced CFC recovery. In addition, IL-3, SCF and IL-6 were cobblestone area) beneath the stromal layer was determined unlikely to mediate the SCM effect because all cultures at weeks 2, 4, 6 and 8 and CAFC frequencies were calculated contained plateau levels of these cytokines. using Poisson statistics as described previously. 18, 21 Statistical analysis Data were analyzed using GraphPad Instat (GraphPad Effect of stroma-conditioned media on primary colony Software, San Diego, CA, USA). The means of two populations formation were compared using a paired Student's t-test. The two-sided P value is determined testing the null hypothesis that the SCM groups are equal to the no SCM group. Only experiments with
We investigated the presence of colony-stimulating and synern greater than 3 were analyzed and marked with an asterisk gistic activities in SCM by studying primary colony formation if P was smaller than 0.05. of CD34 + PBSC in serum-low semisolid culture medium in the presence or absence of the various SCM and cytokine combinations. From these experiments it appeared that L87/4 and Results L88/5 SCM, but not FBMD-1 SCM, contain colony-stimulating factors (Figure 3a and b, upper panels). The two human SCM Progenitor cell expansion in defined medium also showed a strong synergistic effect on colony formation in the presence of IL-3, SCF and IL-6, whereas FBMD-1 SCM The first set of experiments was aimed to characterize optimal mostly stimulated cluster formation (Figure 3a and b, middle cytokine combinations for recovery of hematopoietic progenipanels). The lower panels of Figure 3 show that all three SCM tors from 7-day liquid cultures of CD34 + PBSC. From Figure 1 dramatically increased the number of myeloid and erythroid it is apparent that IL-3, SCF and IL-6 synergized to increase colonies in cultures with a six cytokine (IL-3/SCF/IL-6/Gthe recovery of CFC, while the combination of IL-3/SCF/IL-CSF/GM-CSF/EPO) combination. The observation that FBMD-6/G-CSF/GM-CSF gave the greatest expansion of CFC in these 1 SCM was similarly active as the two human SCM in this liquid cultures. There was no further improvement of this respect suggests that the activities in FBMD-1 act in synergy expansion with the addition of IL-11 (Figure 1) or IL-12 (data with multiple cytokines. Moreover, colonies grown in the not shown) as we have reported in the murine system. [37] [38] [39] presence of SCM were larger. Our observations that the various SCM dramatically enhance the number and size of colonies indicates that the SCM activities trigger more progenitors Effect of stroma-conditioned media on progenitor cell to proliferate and to produce larger clones. This suggests that expansion the SCM activities have an effect on relatively early progenitor cells, while the two human SCM affect more differentiated Subsequently, we studied the effect of SCM on CFC expansion in serum-low liquid cultures. Because the stromal cell lines progeny as well. The effect of stroma-conditioned media (SCM) on primary colony formation by CD34 + PBSC in serum-low semisolid culture medium (n = 4; ±1 s.e.m.). In the upper panels of (a) and (b) the direct colony-stimulating effect of L87/4 and L88/5 SCM is demonstrated. The middle panels of (a) and (b) show the strong synergistic effect of all three SCM on colony formation in the presence of IL-3, SCF and IL-6. The lower panels of (a) and (b) illustrate the SCM effect on colony formation in cultures with a six cytokine (IL-3/SCF/IL-6/G-CSF/GM-CSF/EPO) combination.
primitive CAFC week 6 to 8 stem cell subsets was improved specific anti-cytokine antibodies (ie ␣-G-CSF, ␣-GM-CSF, ␣-IL-11 ␣-LIF) to liquid cultures containing IL-3, SCF, IL-6 and by the addition of SCM. In liquid cultures with FBMD-1, L87/4 and L88/5 SCM there was a 2.2 (range 1.0-3.5), 4.5 (range FBMD-1, L87/4 and L88/5 SCM could not neutralize the SCM effect (Table 4 ). Due to inter-experimental variation the over-0.8-8.1) and 4.9-fold (range 1.0-9.7) expansion, respectively, while we observed maintenance of CAFC weeks 6 and 8 in all expansion of CAFC weeks 4 to 8 seemed lower in the presence of these antibodies. However, the effect of SCM did not the absence of SCM. Although the results in Figure 4 sometimes show large ranges, the effect of SCM was always present disappear with the antibodies and the ratio 'SCM/No SCM' was even higher in the 'with antibodies' groups. in each individual experiment.
Experiments with liquid cultures containing IL-3, SCF and IL-6 showed that the addition of known cytokines (ie G-CSF, Discussion GM-CSF, IL-11) could not explain the FBMD-1 SCM effect, because in all these combinations there was a reproducible
In this study the propagation of different human stem cell subsets and progenitors in a short-term serum-low liquid culture and clear SCM effect (Table 3) . Similarly, addition of species-
Figure 4
The effect of stroma-conditioned media (SCM) on the expansion (±1 s.e.m.) of different CAFC week-types in 7-day serum-low liquid cultures of CD34 + PBSC containing IL-3, SCF and IL-6. Comparison between no SCM and with SCM: *, P Ͻ 0.05; # , n = 4.
Table 3
Effect of FBMD-1 stroma-conditioned media on the expansion of different CAFC week-types in liquid culture (n = 1)
Fold CFC expansion as compared to day 0 (±1 s.e.m)
Cytokine stimulation IL-3/SCF/IL-6/G-CSF/GM-CSF IL-3/SCF/IL-6/G-CSF/GM-CSF/IL-11 Stroma-conditioned media Stroma-conditioned media None FBMD-1 None FBMD-1 CAFC week 2 3.9 5.9 4.2 11.5 CAFC week 4 3.2 9.0 1.5 3.6 CAFC week 6 1.2 3.6 0.5 1.9
system was investigated. The addition of stromal cell line-conunselected PBSC 7, 10, 12 and is in line with the results from 2-week 'stroma-noncontact' cultures of normal bone marrow ditioned media to these short-term cultures significantly improved the expansion of both short-term and long-term culcells.
32
In our attempt to improve further culture conditions, we ture initiating cells. We documented a 10.2-fold expansion of progenitor cells (CAFC weeks 2 to 4) and a 4.9-fold expansion focused on the stromal microenvironment, because it has been shown that stroma-dependent and 'stroma-noncontact' of primitive CAFC weeks 6 to 8 in serum-low liquid cultures of CD34
+ PBSC stimulated with IL-3, SCF, IL-6 and L88/5 cultures support proliferation and expansion of primitive HSC. [13] [14] [15] [16] [17] [18] 20, 21, [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] We investigated the effect of serum-low SCM. This SCM-supported expansion of primitive CAFC weeks 6 and 8 in static cultures was a major improvement as SCM on the expansion of different stem cell subsets in liquid cultures. The addition of SCM from the FBMD-1, L87/4 or compared with similar cultures of long-term culture-initiating cells or late CAFC from CD34-selected PBSC. 6, 12 However, it L88/5 cell lines improved the expansion of a broad spectrum of progenitor and stem cells, including that of the most primimatches with data from continuous perfusion cultures of Table 4 Effect of antibodies against G-CSF, GM-CSF, IL-11 and LIF on stroma-conditioned media-mediated CAFC 
Comparison between no SCM and with SCM: *P Ͻ 0.05.
tive HSC. This improved expansion could not be explained line M2-10B4 indeed improves the maintenance of primitive HSC. Therefore, the synergistic effect of SCM could reflect the by a series of known cytokines because the effect was observed in all cytokine combinations using IL-3, SCF, IL-6, cytokine-presenting capacity of those extracellular matrix molecules, since it has been shown that GAGs and heparan G-CSF, GM-CSF, IL-1␤, IL-11 and MIP-1␣ and also in the presence of neutralizing antibodies for G-CSF, GM-CSF, ILsulphate can bind growth factors and present these factors to the HSC. 44, 45 11, LIF and TGF-␤1. Because SCM was a cell-free supernatant, SCM could also be useful in a clinical setting for improvement of ex vivo culture conditions. Acknowledgements Our data indicate that the SCM affects primary colony formation, the expansion of progenitor cells and the We gratefully acknowledge Prof Dr Bob Löwenberg for proproliferation/survival of more primitive HSC. Other investividing continuous support. We are indebted to Dr Steven gators have shown similar results in stromal cell co-culture Neben for generously providing cytokines and antibodies, and and in 'stroma-noncontact' culture systems.
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